News – Page 443 – Endpoints News

Atlas-backed biotech focused on Huntington's disease shuts down less than three years after launch

3 years ago

Royalty Pharma bets Merck's schizophrenia drug can go where Pfizer, Takeda and Lundbeck's couldn’t

3 years ago

Months after adding $60M to coffers, AI startup Terray nabs discovery pact with Google's Calico

3 years ago

‘Pluck those diamonds’: Bayer’s Vividion eyes up to nine oncology targets from Duke spinout

3 years ago

Michael Ehlers and Romesh Subramanian launch biotech with $50M, sea squirt-inspired RNA-editing tech

3 years ago

Now bankrupt, Zosano sells off its drug delivery tech that once enticed Novo Nordisk, Eli Lilly

3 years ago

Sangamo gives another update on early-stage Fabry program, enters trial expansion phase

3 years ago

FDA settles drug compounding suit, agrees to speed its review of bulk ingredients

3 years ago

Walmart buys into pharma research, following in footsteps of CVS and Walgreens

3 years ago

Amneal lays off more than a dozen employees at Long Island facility as operations wind down

3 years ago

FDA signs off on GSK label expansion for Tdap vaccine

3 years ago

More early data manipulation issues tied to Novartis blockbuster as Nature retracts paper

3 years ago

AstraZeneca and GSK settle talent feud in court — again

3 years ago

MarketingRx roundup: Pharma, agencies turn up for World Mental Health Day; Horizon, Vertex make best workplace list

3 years ago

#PharmaTok: Amgen, AZ join growing number of pharma marketers on the social video channel

3 years ago

Pfizer exec denies vaccine negotiations via text message in grilling before European Parliament

3 years ago

Updated: DICE rolls on as lead oral IL-17 candidate meets proof-of-concept in PhI trial, sending shares higher

3 years ago

Rigel steps back from sNDA filing plans for bleeding disorder drug; NMD gives first look into myasthenia gravis ...

3 years ago

FDA reveals QC issues at Eli Lilly’s manufacturing site in New Jersey — report

3 years ago

Eli Lilly tasks Nimbus with hitting a 'high-value' target for diabetes, obesity

3 years ago

Another biotech CEO departs, leaving behind few employees for PhIII

3 years ago

Illumina continues trek into drug discovery, inks AI pact with AstraZeneca

3 years ago

No speedy nasal rollout for Oxford/AstraZeneca’s Covid-19 jab after PhI flop

3 years ago

PureTech, Nektar put an end to deal discussions, citing too much 'uncertainty'

3 years ago

First page Previous page 440 441 442443444 445 446 Next page Last page